Business

On a path to recovery: 4 small and mid cap pharma stocks with an upside potential up to 25 %

By Dan Neff

Suven Pharmaceuticals Limited is a company that is primarily engaged in providing services to global life science and fine chemical, including custom synthesis, process research and development, scale up and contract manufacturing of intermediates, active pharmaceutical ingredients (APIs) and formulations.

Synopsis

Pharma as a sector has been under pressure for a very long time. However, some of the small and mid sized Indian pharma companies which are not hit by pricing pressure of the US generic market and other issues which large pharma companies have been facing keep attracting interest from the analyst. The list is based on upside estimated by the analysts, with the highest potential stock coming on the top of the list.

Pharma as a sector has been witnessing a mixed newflow. Select domestic pharma companies which have been pushing for backward integration have seen some improvement in their margins. At the same time some headwinds have again resurfaced for large pharma companies whose fortunes are tied up with pricing trends in US markets. Pricing pressure in generic drugs is back on the table for these large pharma companies. Though in last few months, the

ETMarkets.com

6 mins read, Last Updated:

  • FONT SIZE

    AbcSmall

    AbcMedium

    AbcLarge

  • SAVE
  • PRINT
  • COMMENT

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Read this story for free.

Unlock your 30 days free access to ETPrime now.

Login to unlock

*No card details required.

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

  • ​Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-​

For all the latest Business News Click Here 

 For the latest news and updates, follow us on Google News. 

Read original article here

Denial of responsibility! TheDailyCheck is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected] The content will be deleted within 24 hours.

Dan Neff